Mount Sinai has one of only 10 centers of excellence for sarcoidosis research in the world, and we bring our scientific advances directly to our patients through clinical research and clinical trials.

The sarcoidosis program, led by Adam Morgenthau, MD, is exploring the biology of the disease in order to increase our understanding of how the condition itself develops and advances. It is also investigating areas such as examining forced oscillometry to measure lung function in patients with sarcoidosis. Our studies include a clinical trial to evaluate the safety and efficacy of treating sarcoidosis with Kiacta to gain a better understanding the mechanisms underlying formation of granulomas in the condition.